National Coordinating and Evaluation Center
Cincinnati Children's Hospital Medical Center (Cincinnati, OH) Print

Cincinnati Comprehensive
Sickle Cell Center (CCSCC)

Project Title: Improving Hemoglobinopathy Screening Follow-up and Service for Affected Families in Cincinnati
Principle Investigator: Nona R. Calhoun-Mumia, M.S., CHES
Organization: Cincinnati Children’s Hospital Medical Center
Address: 3333 Burnet Ave, Cincinnati, Ohio 45229-3039
Contact Person: Nona R. Calhoun-Mumia, M.S., CHES
Phone: 513.636.8086 Fax: 513.636.5562
E-mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Web site: http://www.cincinnatichildrens.org/

Purpose

The Purpose of Improving Hemoglobinopathy Screening Follow-up and Services for affected families in Cincinnati Project is to improve newborn screening follow-up for sickle cell disease and trait both short term and long term, to enhance community and national awareness and support of sickle cell issues, and to develop a community-based support system for families affected by sickle cell disease.

Challenges

Despite the CCSCC’s thirty-year experience in newborn screening, follow-up for sickle trait is only 30% of the 500-600 infants per year in our region with trait receive confirmatory test­ing. We believe concerted effort by a network of primary health care providers, social service, educational, corporate systems; state and national institutions as well as the community at large is needed to achieve the MCHB National agenda for CSHCN: family participation and satisfaction; access to medical home; access to affordable insurance; early and continuous screening; easy-to-access, community-based services systems; services necessary to transition to adulthood. Sustaining an effective community-based support system for families within a CBO is a challenge. Other challenges include partnering with families with abnormal hemoglobin newborn screening results, assessing their needs and educating health professionals both obstetricians and pediatricians on policies and procedures needed to address those needs. On state and national levels, coordination and sharing of resources for prenatal screening, counseling, education and newborn screening follow-up is needed to create a seamless sys­tem of genetic, medical and psycho­social services for those affected by or at risk for sickle cell disease.

Goals and Objectives

Specific Goals for this project are to:

  1. Develop a comprehensive, community-based support system within the Sickle Cell Awareness Group of Greater Cincinnati, Inc. for affected individuals and families, and increase community awareness of sickle cell trait and its implications.
  2. Improve follow-up for infants identified with sickle trait through enhance professional and patient education at the obstetrical level.
  3. Collaborate with Ohio Regional Sickle Cell Program and Ohio State Public Health Laboratory in providing services for individuals and families affected by sickle cell disease.
  4. Collaborate with the National Coordinating Center (Project 1) to develop certification standards for hemoglobinopathy counseling, to provide data management tools and educational material for newborn screening follow-up to local and regional community-based programs.

Methodology

The CCSCC will provide leadership for the partnership of community-based sickle cell organization SCAG, health care providers, Ohio state sickle cell program, Title V, Ohio laboratory in the effort to identify the needs of families with abnormal hemoglobin newborn screening results in this region. SCAG will sustain a community-based family support group by recruiting affected families through the CCSCC, involving community volunteers and organizations in support group activities, and edu­cating the general public about sickle cell issues, including the need for follow-up of newborn diagnosis of trait. The CCSCC will conduct a program of education, counseling and publicity targeting obstetricians and prenatal clients, to increase utilization of prenatal screening to improve the rate of trait follow-up for newborns. The CCSCC and SCAG will contribute their three dec­ades of expertise and materials on partnership, counselor training and data management for prenatal and newborn screening and collaboration to the national effort embodied in Project 1 to standardize and expand these efforts.

Evaluation

The evaluation plan includes an ongoing assessment of project effectiveness in meeting the goals, objectives, outcomes and performance indicators outlined in Quantitative and Qualitative Work Matrix (Attachment I). Attendance and utilization data, satisfaction surveys will assess the effectiveness of the project in meeting client needs. A project valuator and cultural anthropologist consultant will work with the principle investigator and staff to provide information to evaluate the overall effectiveness of the interventions.

Experience to Date

The CCSCC and SCAG have a thirty-year history of collaboration and service to the sickle cell community. As a partner in the Cincinnati Sickle Cell Center Grant from NIH, SCAG participates in the CCSCC Transition Project. As a FY2002 HRSA funded grantee in the Sickle Cell Newborn Screening Program, our collaboration has achieved strengthening community support, evaluating the needs regarding newborn screening follow-up for hemoglobinopathies at the obstetric level and educating both consumers and professionals.

Text of Annotation

This collaborative effort by an established treatment-center (CCSCC) and a community-based organization (SCAG) addresses the dual problems of inadequate follow-up for sickle cell trait and the lack of community-based support services for affected families. We aim to improve follow-up by an educational effort targeted to obstetricians and prenatal clients, as well as the community at large. We will contribute to the national effort to improve sickle cell services by contributing the expertise and materials in prenatal diagnosis, sickle cell counseling, and new­born screening data management developed by the CCSCC and SCAG in three decades of service to the sickle cell community.

 

Welcome to the website of the National Coordinating and Evaluation Center- SCDAA for the Sickle Cell Disease Newborn Screening Program. Please take a moment to read the following statement regarding policy, confidentiality, and disclaimers. Once you click your acceptance below, you will be free to navigate throughout the site. Thank you for your cooperation, and enjoy your visit!

TERMS AND CONDITIONS OF USE OF SICKLECELLDISEASE.NET

AGREEMENT

BY ENTERING THE NCEC-SCDAA SITE, YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE READ AND UNDERSTAND THESE TERMS AND CONDITIONS OF USE OF SICKLECELLDISEASE.NET, THAT THE PROVISIONS, DISCLOSURES AND DISCLAIMERS SET FORTH BELOW ARE FAIR AND REASONABLE, AND THAT YOUR AGREEMENT TO FOLLOW AND BE BOUND BY THEM IS VOLUNTARY AND IS NOT THE RESULT OF FRAUD, DURESS OR UNDUE INFLUENCE EXERCISED UPON YOU BY ANY PERSON OR ENTITY. YOU ALSO AGREE TO HOLD NCEC AND ITS GRANTEES, AND EACH OF THEIR OFFICERS, DIRECTORS, MEMBERS, AND AGENTS HARMLESS FROM ANY CLAIM, COMPLAINT OR DAMAGE ARISING OUT OF OR IN CONNECTION WITH YOUR USE OF THE SITE.

SUMMARY OF IMPORTANT LEGAL INFORMATION

The sicklecelldisease.net website (the "Site") is produced for the National Coordinating and Evaluation Center (NCEC) -SCDAA, the grantees participating in the Sickle Cell Disease Newborn Screening Program and their partners. All use of the Site is subject to the Terms and Conditions set forth below. By entering and using the Site, you acknowledge that you have read and understood such Terms and Conditions and that you agree to abide by them. The Site is designed for informational and educational purposes only. NCEC does not endorse, guarantee, warrant, or recommend any products or services discussed or advertised on the Site or linked from the Site. The NCEC-SCDAA retains all copyrights and other proprietary rights in or relating to any content, including any software or educational materials, provided on the Site. You may download and print a small number of copies of the content for scientific or educational uses. You may not sell, transfer, reproduce, transmit, distribute, perform or display such content for any commercial purpose without the express consent of the NCEC-SCDAA.

PRIVACY POLICY NCEC-SCDAA provides the following privacy policy (the "Privacy Policy") in order to demonstrate our firm commitment to privacy. The Privacy Policy may be amended from time to time. The NCEC home page will indicate the date that the Privacy Policy was most recently updated.

a. Collection of Personal Information. NCEC -SCDAA may ask for information about our users at the point of downloading educational materials. This information tells us about the types of people (e.g., providers vs. patients, grantees vs. nongrantees) who use the Site and helps us in the development of materials for our grantees and their clients.

b. Use of Personally Identifiable Information. NCEC-SCDAA will not sell or otherwise transfer or disclose personally identifiable information to third parties without the user's prior consent except as may be required by federal, state or local law, or by exigent circumstances. NCEC-SCDAA also may use your profile information on an aggregate basis -- without personal identifiers -- to develop and display new features and content for the Site, and to provide others with aggregate information about our users and the usage patterns of the Site. NCEC-SCDAA also may perform statistical analyses of user behavior (on a de-identified aggregate basis) in order to measure interest in and use of the various areas of the Site.

c. Retention of User Information. It is not possible for a user to delete his or her profile from our database, nor is it feasible to delete all traces of a user's activity in the system. Messages posted to a forum are examples of user activities that are not feasible to delete.

d. Voluntary Disclosure of Personally Identifiable Information on Forum Boards. Users should be aware that when they voluntarily disclose personally identifiable information (for example user name, email address) on an Interactive Area of the Site, that information, along with any substantive information disclosed in the user's communication, can be collected and correlated and used by third parties and may result in unsolicited messages from third parties. Such activities are beyond the control of the NCEC and the NCEC is not responsible for the discoverability of any user's identify by methods beyond our control.

e. Cookie Technology. NCEC collects non-personal identification information through the use of "cookie" technology and/or Internet Protocol ("IP") address tracking. Cookies are small text files a website can use to recognize repeat users and facilitate the user's ongoing access to and use of the site. Non-personal identification information might include the browser used by the user, the type of computer, the operating systems, the Internet service providers and other similar information. The NCEC system also automatically gathers information about the areas the user visits on the Site and about the links the user may select from within the Site to other sites. NCEC cannot control the use of cookies by advertisers or third parties displaying data on the Site or whose sites a user visits or links to from the Site. Most browsers are set to accept cookies. You can set yours to refuse cookies, or to alert you when cookies are being sent.

f. Links to other sites. The Site contains links to third party websites. These links are provided solely as a convenience to users and not as a guarantee, warranty, or recommendation by NCEC of the content on such third-party websites or as an indication of any affiliation, sponsorship or endorsement of such third party websites. NCEC is not responsible for the content of linked third-party sites and does not make any representations regarding the privacy practices of, or the content or accuracy of materials on, such third-party websites. If you decide to access linked third-party websites, you do so at your own risk. Your use of third-party websites is subject to the terms of use for such sites.

g. Security of Information. NCEC is committed to keeping user information secure, and uses industry standard technology in an attempt to achieve that goal.

h. Parental Permission. NCEC does not intend that children will use the Site. Some of the information available on the Site may not be appropriate for children. USERS UNDER 18 YEARS OF AGE MUST OBTAIN PARENTAL PERMISSION TO USE THE SITE. Adults should not assist unauthorized children to access the Site. NCEC will not knowingly collect, use or disclose personally identifiable information about visitors under 18 years of age.

     

For security reasons,
you must accept the Term and Conditions of SICKLECELLDISEASE.NET
in order to be able to navigate throughout the site.
Thank you.
Disclaimer
Home